← All patents

US11713313B2

GLS1 inhibitors for treating disease

University of Texas System

Abstract

Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I:Methods of inhibition GLS1 activity in a human or animal subject are also provided.

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Richard Thomas Lewis
Priority date
June 30, 2015
Filing date
July 01, 2020
Grant date
August 01, 2023
Publication date
August 01, 2023
Language
en
Metadata fetched
August 29, 2026 00:30